© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Exocrine Pancreatic Insufficiency
Ultrasounds Help Identify Advanced Cystic Fibrosis Liver Disease
February 29, 2020
Article
Advanced cystic fibrosis liver disease manifests as portal hypertension with or without cirrhosis in about 7% of patients with cystic fibrosis.
Cannabis Users With Acute Pancreatitis Less Likely to Have Necrosis, Fluid Collections
October 31, 2019
Article
In a pioneer study, investigators investigate if cannabis users had less incidence of pancreatic necrosis and/or pancreatic/peripancreatic fluid collections.
Roberto Simons-Linares, MD: How a Hepatitis Viral Infection Causes Acute Pancreatitis
October 30, 2019
Article
Roberto Simons-Linares, MD, presents new data at the annual ACG meeting on the association between hepatitis viral infections and acute pancreatitis.
Roberto Simons-Linares, MD: The Impact of Cannabis Use for Acute Necrotizing Pancreatitis
October 29, 2019
Article
During the annual ACG meeting, Roberto Simons-Linares, MD explained how cannabis use impacts the fluids of patients suffering from acute necrotizing pancreatitis.
FDA Approves Triple Therapy to Treat Cystic Fibrosis
October 21, 2019
Article
The newly approved drug is a combination of 3 drugs that target the most common cystic fibrosis mutation.
FDA Approves Symdeko Tablets for Ages 6 and Older
June 21, 2019
Article
The FDA had previously only certified Symdeko tablets for treatment of children aged 12 years and older.
Catastrophizing and Cystic Fibrosis: Fear of Breathlessness Impacts Quality of Life
October 15, 2018
Article
Results connecting breathlessness catastrophizing with reduced quality of life also have implications for populations with asthma or COPD.
Antibiotics for CF Lung Infections Influenced by Oxygen, pH
October 02, 2018
Article
Upon finding pH and oxygen may influence how antibiotics perform in CF lung infections, investigators suggest a one-size-fits-all therapy approach may not be the best treatment.
Telavancin: Promising Treatment Option for MRSA in Cystic Fibrosis Patients?
September 10, 2018
Article
Investigators find telavancin has potent in vitro activity and low resistance development potential when used against S aureus isolates in patients with cystic fibrosis.
Top 5 Rare Disease News of the Week—August 12, 2018
August 18, 2018
Article
Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.